Tech Company Financing Transactions
ImaRx Therapeutics Funding Round
ImaRx Therapeutics secured a $13 million funding round on 6/30/2006. Investors included Boston Scientific Corporation and Solstice Capital.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
P.O. Box 968
Round Rock, TX 78680
USA
Round Rock, TX 78680
USA
Phone
Website
Email Address
Overview
We are a biopharmaceutical company developing and commercializing therapies for vascular disorders. Our research and development efforts are focused on therapies for stroke and other vascular disorders, using our proprietary microbubble technology to treat vascular occlusions, or blood vessel blockages, as well as the resulting ischemia, which is tissue damage caused by a reduced supply of oxygen.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bradford Zakes
VP - General Counsel
Kevin Ontiveros
Browse more venture capital transactions:
Prev: 6/30/2006: Mochila venture capital transaction
Next: 6/30/2006: Clearsight Systems venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs